Avio Smart Market Stack Equity Investment In Huwel Lifesciences; Shares Fall 4.84%

Mumbai, March 11: Avio Smart Market Stack Limited disclosed on Wednesday that it has made an equity investment in Huwel Lifesciences Private Limited amounting to ₹7.50 crore, according to a regulatory filing submitted to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure stated that the company acquired 9,665 equity shares of the target entity at ₹7,760 per share, representing a 2.11% stake in the lifesciences firm.

The company clarified that the acquisition does not fall within the ambit of related party transactions. It also confirmed that the promoter or promoter group has no interest in the target entity. The investment is structured as a cash consideration and has been executed at arm’s length, as stated in the exchange disclosure.

According to the filing, the first tranche of the transaction has already been completed, while the remaining tranches will be executed in accordance with the terms outlined in the shareholders’ agreement between the parties.

Share Price Movement

Shares of Avio Smart Market Stack Limited were trading lower on March 11, 2026. As of 16:01 IST, the stock was quoted at ₹8.85 on the exchange, down ₹0.45 or 4.84% compared with the previous close of ₹9.30, according to exchange data.

During the trading session, the stock opened at ₹9.55 and moved within a day’s range of ₹8.78 to ₹9.67.

Target Company Operations And Business Profile

Huwel Lifesciences Private Limited operates in the lifesciences and healthcare diagnostics segment. The company develops, manufactures and supplies molecular diagnostic kits, medical devices and in vitro diagnostic solutions used for disease detection and healthcare testing.

The enterprise primarily supplies products to hospitals, laboratories and research institutions. Its operational focus lies in diagnostic technologies supporting healthcare screening and laboratory analysis.

Corporate records indicate that Huwel Lifesciences Private Limited was incorporated on 10 February 2015 and is headquartered in Patancheru, Telangana, India.

Financial disclosures included in the filing show that the company recorded turnover of ₹12.11 crore in FY2022-23, ₹4.94 crore in FY2023-24 and ₹15.74 crore in FY2024-25.

Strategic Rationale For The Transaction

The investment has been undertaken with the objective of deriving operational and financial synergies, the company said in the regulatory disclosure. By acquiring a minority stake in a diagnostics and healthcare technology business, Avio Smart Market Stack aims to expand strategic exposure to the lifesciences ecosystem.

No governmental or regulatory approvals were indicated as necessary for completing the acquisition. The remaining investment tranches will proceed as per the contractual terms agreed between the shareholders.

Source:

• https://www.bseindia.com/stock-share-price/bartronics-india-ltd/asms/532694/
• https://www.bseindia.com/xml-data/corpfiling/AttachLive/cfc7fd9f-a058-4fdc-8a7e-d91c14f381ba.pdf